Table 2.
β | 95% CI | P value | |
---|---|---|---|
Subjects with T2D (n = 224)* | |||
Variable | |||
Age | −0.104 | −0.172 to −0.036 | 0.003 |
Male sex | 2.345 | 0.909 to 3.781 | 0.001 |
White ethnicity | 1.415 | −0.041 to 2.871 | 0.057 |
Never smoked | 2.034 | 0.193 to 3.874 | 0.030 |
Systolic blood pressure | −0.017 | −0.062 to 0.027 | 0.443 |
LV EF | −0.041 | −0.150 to 0.067 | 0.453 |
LV GLS | 0.214 | −0.072 to 0.499 | 0.142 |
Myocardial perfusion reserve | 0.822 | 0.235 to 1.409 | 0.006 |
Average E/e′ | −0.388 | −0.595 to −0.180 | <0.001 |
Control subjects (n = 78) | |||
Variable | |||
Age | −0.446 | −0.563 to −0.329 | <0.001 |
Male sex | −0.461 | −3.596 to 2.675 | 0.773 |
White ethnicity | 2.929 | −0.220 to 6.078 | 0.068 |
Never smoked | −5.636 | −12.185 to 0.914 | 0.092 |
Systolic blood pressure | −0.037 | −0.125 to 0.052 | 0.417 |
LV EDV | <0.001 | −0.072 to 0.072 | 0.998 |
LV EF | −0.143 | −0.375 to 0.089 | 0.227 |
LV mass | 0.116 | 0.026 to 0.206 | 0.012 |
Boldface type indicates P < 0.05.
EDV, end-diastolic volume.
Excluding subjects with peak RER <1 on CPET.